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ABSTRACT We studied specific membrane-membrane interactions mediated by ligand-receptor binding in a model system, which
consisted of (a) FG3P, the fluorescein hapten attached to a phospholipid by a peptidyl spacer as described previously (Petrossian, A.,
A. B. Kantor, and J. C. Owicki. 1985. J. Lipid Res. 26:767-773), (b) antifluorescein monoclonal antibodies (MAbs), and (c) phospho-
lipid vesicles (liposomes) into which the FG3P was incorporated. The aggregation of the hapten-bearing liposomes by four MAbs was
studied by differential centrifugation. The ability of the MAbs to induce vesicle aggregation varied considerably and correlated inversely
with affinity. Aggregation by one of the MAbs was studied in more detail by turbidimetry and freeze-fracture electron microscopy of
samples frozen throughout the course of the aggregation. Rapid freezing was achieved with a double propane-jet apparatus. The
aggregate morphologies and the time evolution of the aggregate size distribution were obtained from the two-dimensional fracture views
with a stereological correction. The aggregation kinetics were simulated by considering dynamical aggregation according to a mass-ac-
tion model with two parameters, the rate constants for antibody-mediated vesicle aggregation and disaggregation. Both rate constants
were orders of magnitude lower than the rate constants for the corresponding interactions of antibodies with haptens either in solution or
on vesicles under nonaggregating conditions.
INTRODUCTION
Interactions between biological surfaces that are me-
diated by surface-bound ligands and receptors are funda-
mental to many significant events in biological systems,
such as cell-cell (Edelman, 1983; Bongrand and Bell,
1984; Springer, 1990) or virus-cell interactions (Ohni-
shi, 1988; Hoekstra and Kok, 1989; Nir et al., 1990).
However, characterization of the kinetic and equilib-
rium parameters of those interactions in most cellular
systems has been difficult due to the complexity of the
system.
We reported a model system constructed in our labora-
tory to investigate several aspects of the ligand-receptor
interaction at membrane surfaces (Petrossian and
Owicki, 1984; Stanton et al., 1984; Petrossian et al.,
1985). The membrane used was a well-defined lipid vesi-
cle into which a hapten, fluorescein, was readily incorpo-
rated at a controllable concentration. The fluorescein
was anchored to the bilayer through a tripeptide (gly3)
linkage to dipalmitoyl-phosphatidylethanolamine, a con-
struct called FG3P. The ligands in solution were mono-
clonal antibodies (MAbs) with known affinity constants
specific for the fluorescein moiety of FG3P. Those stud-
ies were confined to intravesicle binding of the antibod-
ies, where an antibody bound to one or two haptens on
the same vesicle.
Here we focus on intervesicle binding, where the anti-
body cross-links haptens on two liposomes, aggregating
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them. This process mimicks membrane-membrane in-
teractions via specific ligand and receptors as well as the
agglutination reaction ofantigens by antibodies, which is
part of the defense mechanism in the immune system. It
also has direct applications to immunoassays based on
liposome aggregation (Kung et al., 1985; Mansbach et
al., 1985).
We have used complementary methods to study the
aggregation process at its late and early stages. As we
indicated in a preliminary report, differential centrifuga-
tion gives information about the formation of large ag-
gregates late in the process (Kantor et al., 1986). Here
we report results for four different antifluorescein MAbs.
We have studied the early stages ofaggregation ofvesi-
cles by one ofthe MAbs in detail, using turbidimetry and
freeze-fracture electron microscopy (EM) to yield infor-
mation about kinetics ofaggregation and morphology of
the aggregates. Turbidimetry has been used previously to
study the aggregation of negatively charged vesicles in-
duced by high concentration of Na+ (Day et al., 1980),
as well as that of glycolipid-containing liposomes me-
diated by specific lectins (Curatolo et al., 1978; Goodwin
et al., 1982). Turbidimetry, like most spectroscopic
methods, monitors only average parameters related to
bulk properties of the aggregation state. Microscopic vi-
sualization makes it possible to estimate the distribution
of the sizes of aggregates. We have interpreted the EM
data using a model of dynamic aggregation previously
developed to treat cation-induced vesicle aggregation
(Bentz and Nir, 1981; Nir et al., 1983), modified here to
account for specific ligand-receptor interactions.
EM also reveals the morphology of the aggregates, as
has been shown in previous studies on the cation-in-
duced aggregation of vesicles (Day et al., 1980; Hui et al.,
1988). Here we report for the first time morphological
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TABLE 1 Characteristics of MAbs
MAb Isotype K*
2-3-6 IgG, 500
2-27-12 IgG, 60
4-4-20 IgG2. 1,000t
6-19-1 IgG2b 3
* Affinity for sodium fluorescein; affinity ofFab for FG3P on vesicles is
equivalent. Conditions: BBS, pH 8.5, 25°C.
t Affinity for hapten on vesicles increases beyond this value for incuba-
tions lasting hours (Kantor, 1988).
information on aggregates induced by a specific ligand-
receptor interaction.
MATERIALS AND METHODS
Liposomes
The lipid vesicles (liposomes) used were composed of dipalmitoyl-
phosphatidylcholine (DPPC)/cholesterol (2:1). The DPPC (Avanti
Polar Lipids, Birmingham, AL) was one spot on thin layer chromatog-
raphy with developing solvents (chloroform/methanol/water =
65:25:4) and (chloroform/methanol/acetic acid/water = 65:25:4:2)
on analytical silica gel 60 plates (E. Merck, Darmstadt, Germany).
FG3P was prepared as reported previously (Petrossian et al., 1985).
The lipids were dissolved in chloroform and mixed with FG3P dis-
solved in methanol. The mixture was completely dried in a round-bot-
tom flask by rotary evaporation (Haake-Buchler, Saddle Brook, NJ).
The lipids were hydrated overnight at 50°C with borate buffered saline
(BBS; with 25 mM borate, at pH 8.5, and at osmolarity of 310 mosM
adjusted with NaCl, using a freezing-point depression osmometer).
The resulting multilamellar vesicles went through five cycles offreezing
(liquid nitrogen) and thawing (50°C) and were subsequently extruded
through filters of defined pore sizes as described in Szoka et al. ( 1980)
and Mayer et al. ( 1986). The extrusion was through two stacked poly-
carbonate filters (Nuclepore, Pleasanton, CA) of final pore size 50 nm,
by a high-pressure vesicle extruder (HPVE-10, Sciema Technical Ser-
vices, Richmond, BC, Canada) at 50°C, yielding essentially unilamel-
lar vesicles with a size distribution of diameters having a mean of 58.1
nm and standard deviation of 11.4 nm, based on a stereological analy-
sis of freeze-fracture data (Lee, 1988). Some nonspecific formation of
small aggregates developed over a period of several days. Therefore,
experiments were performed on vesicles within 3 d of preparation
(.90% monomers by EM).
Antibodies
Four hybridomas secreting antifluorescein antibodies were obtained
from E. W. Voss, Jr. (University of Illinois, Urbana) (Kranz and Voss,
1981; Reinitz and Voss, 1984). The MAbs were purified from Balb/c
ascites fluid by protein A affinity chromatography, as described by
Kantor (1988). Before experiments, stock antibody solutions were
centrifuged at 60,000 g for 45 min to eliminate aggregated antibodies.
Table 1 lists the identifying numbers, isotypes, and affinities toward
sodium fluorescein for the MAbs. Affinities were determined by the
quenching of hapten fluorescence in BBS at 25°C as described by Pe-
trossian and Owicki ( 1984).
The affinities for FG3P were obtained with Fab fragments ofthe four
MAbs, which were prepared by papain digestion (Kantor, 1988). Ex-
cept for MAb 4-4-20, the affinity ofeach fragment for FG3P on vesicles
was nearly equivalent to the affinity of the native antibody for sodium
fluorescein (i.e., to within 20%), asjudged by the fluorescence-quench-
ing assay. For binding on the time scale of minutes, the Fab fragments
of MAb 4-4-20 also displayed the same affinity for hapten-containing
vesicles as for sodium fluorescein. However, on the time scale of hours
the affinity increased, becoming at least 10-fold higher by 24 h. The
cause ofthis phenomenon is unknown, but the intact MAb also showed
a time-dependent increase in functional affinity (Kantor, 1988).
Differential centrifugation
for large precipitants
The vesicles contained 0.25-2.0 mol% FG3P and were radiolabeled
with '4C-DPPC (Amersham, Arlington Heights, IL). Before the addi-
tion of antibody, they were centrifuged at 12,000 g for 30 min to re-
move a small number of nonspecific aggregates. Antibodies and vesi-
cles were mixed in microfuge tubes and incubated for up to 24 h.
Differential centrifugation monitors the formation of aggregates that
are large enough to precipitate under the experimental conditions;
smaller ones remain in solution. If an antibody-coated vesicle has a
density of 1.05 g/ml, then centrifugation at 12,000 g for 5 min over a
distance of 5 mm should substantially pellet aggregates with a radius
>2 x I0- cm. Thus, aggregates ofmuch fewer than 100 vesicles should
remain in the supernatant. The radioactivity in an aliquot ofthe super-
natant was used to monitor the centrifugal separation.
Turbidity measurements
The turbidity was measured in a spectrophotometer (Beckman Instru-
ments, Inc., Fullerton, CA) in kinetic mode at wavelength 680 nm,
path length 1 cm. The turbidity change is expressed as a percent of
initial turbidity. The initial turbidity (O.D.) at time zero is set equal to
the optical density of liposomes without antibodies, corrected for the
dilution.
Freeze-fracture EM
The time course of the aggregation initiated by addition of antibody
was directly visualized by freeze-fracture EM. The aggregation reaction
was carried out at room temperature without stirring. Periodically,
small aliquots were withdrawn for analysis, and a rapid-freezing
method was applied to stop the process of aggregation in milliseconds.
The freezing method has been described in our previous technical
reports (Lee and Owicki, 1989a, b). Briefly, the liposomes were sand-
wiched between two copper specimen carriers (BU 012 056-T; Balzers,
Hudson, NH) with a 400 mesh EM grid attached to each carrier and
rapidly frozen by a Gilkey-Staehelin propane jet ultrarapid freezer
(model MF7200; Research & Manufacturing Co., Tucson, AZ) (Gil-
key and Staehelin, 1986). Such rapid-freezing methods have proved
superior to conventional immersion-freezing methods in other mor-
phological and quantitative studies (Heuser and Reese, 1981; Bearer et
al., 1983; Kachar et al., 1986; Hui et al., 1988).
The cryo-fixed liposome solution was fractured in a Balzers Freeze-
Etch unit BA360M with double replica device (BB 187 269-T;
Balzers). The replicas were examined in a Zeiss 109 (Carl Zeiss Inc.,
Thornwood, NJ) or JEOL IOOCX (JEOL U.S.A. Inc., Peabody, MA)
electron microscope. Micrographs from two independent runs of ex-
periments were pooled to construct the evolution of aggregate size dis-
tribution. For each time point, 400-1,000 vesicles were counted to
obtain the apparent distribution of monomers, dimers, and so on.
Analysis of antibody-vesicle binding
before aggregation
The following conditions of lipid, hapten, and antibody concentration
were used for the EM experiments. For 10 mM DPPC, 5 mM choles-
terol, and a mean vesicle diameter of 58 nm, the concentration of
liposomes is 0.4,uM. The hapten FG3P was introduced as 0.05 mol% of
lipid or a mean of 12 on the outer lipid monolayer of a vesicle, assum-
ing the same lateral density of FG3P on the inner and outer mono-
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layers. Given a concentration of 850 nM antibody binding sites and
assuming bivalency, there were 1.1 antibody molecules per vesicle in
the system.
Before calculating the kinetics of vesicle aggregation, we calculated
the distribution of vesicles containing 0, 1, 2 antibodies. Antibod-
ies were assumed to bind monovalently to haptens on vesicles; the
concentrations of bound and free antibodies and haptens were ob-
tained by solving the following equation:
MAb*H/[(MAbo - MAb*H)(Ho-MAb-H)] = 2K, (1)
where MAbo and Ho are the total concentrations of antibodies and
(external) haptens, and MAb * His the concentration ofboundantibod-
ies or haptens. K is the affinity constant, and factor oftwo accounts for
the bivalency of the antibodies.
For MAbo = 0.43 MM, Ho = 4.5 AM, and K = 3 (gM)-', 96% ofthe
antibodies and 9% ofthe haptens were bound. The distribution ofanti-
bodies on vesicles was obtained from the binomial distribution, assum-
ing that antibodies bound independently and with equal probability to
each of 12 haptens on a vesicle. The percentages of vesicles containing
0, 1, 2, 3, and >3 antibodies were, respectively, 32, 38, 21, 7, and 2.
Some of the antibody may bind bivalently to a single vesicle and
hence possibly be unavailable to participate in the aggregation process,
at least at short times. Thus, computations were also done assuming
30% intravesicular bivalent binding.
Construction of the stereologically
corrected distribution of aggregate
sizes from the apparent distribution
The apparent aggregate size distribution was obtained by counting the
liposomes in the freeze-fracture replicas. When the fracture passes
through an aggregate, it may not reveal all the vesicles in the aggregate;
the apparent size distribution tends to be skewed toward smaller aggre-
gates. A precise correction for this process would take into account the
morphologies of the aggregates and the factors that influence the path
of the fracture (e.g., whether it passes straight through aggregates or
follows the contours of the vesicles within a cluster). An opposite bias
in the apparent distribution (toward large aggregates) would occur if
the fracture preferentially occurred at large aggregates, which are re-
gions of low resistance to fracture. In the absence of clear information
about these effects, we have presented the apparent distribution and a
corrected distribution based on an approximate stereological treat-
ment.
Let P( m, n) be the probability that an actual n-mer, once sectioned
by the fracture plane, appears as an m-mer (m < n) in the freeze-frac-
ture replica. Monomers always fracture as monomers; P( 1, 1 ) = 1. The
probability that a dimer appears as a monomer, P( 1, 2), is equal to 1 -
P(2, 2). The value of P(2, 2) is rigorously one half for spheres ofequal
size in contact and an unbiased fracture plane, as is illustrated in Fig. 1.
The calculation for trimers is more complex, since morphology plays
a great role in determining the probability. Not fully accounting for
three-body correlations among vesicle positions, we approximate P( 1,
3)byP(1,2)xP(1,2)= 1/4,andsoP(2,3)+P(3,3)= I -P(1,3)=
¾/4. The conditional probability of the third vesicle being cut by the
fracture plane when the other two are already cut is about the same as
P(2, 2). Therefore, P(3, 3) P(2, 2) [P(2, 3) + P(3, 3)]. This
suggests the following recursion relationship that approximates
P( m, n) for larger aggregates:
form =1, P(l, n) =(/2)"-1,
and
form> 1,
P(m, n) = [1 - P(l, n)] X P(m - 1, n - 1). (2)
r + (r - x)-2r - x
r - r - x) = x
x
sin d =
2r-xsin db =
FIGURE I Calculation of P( 1, 2). P( 1, 2), the probability that a frac-
tured dimer appears as a monomer, is represented in the upper cartoon
by the shaded area on the surface of a sphere with a radius 2r; r is the
radius ofthe vesicle and r - x is the distance between the fracture plane
and the center of the first vesicle fractured. The center of the second
vesicle can be randomly positioned on the surface of the sphere with
radius 2r. Then P(2, 2), the probability that the fracture passes
through the second vesicle, is equal to the probability that angle X lies in
the range (-0,, +02), where sin (0,) = x/2r, sin (402) = (2r- x)/2r.
Thus, P( 1, 2) = 1 -P(2, 2) = I/2.
The stereological correction is performed by solving a system of linear
equations. A corrected distribution (c,, c2, . . ., cn) is calculated from
the apparent aggregate size distribution (a,, a2, . . ., an) according to
the matrix equation a = Pij x cj, where as and c;represent the molar
concentrations of i-mer and Pij = P( i, j).
Theoretical procedure for calculating
kinetics of antibody-induced
aggregation of vesicles
A comprehensive theoretical model ofthe aggregation would take into
account factors such as the polydispersity of both antibodies and hap-
tens on vesicles, perturbations of antibody-vesicle binding by the ag-
gregation process, and the morphology ofthe aggregates. Such a model
would be difficult to construct, and its validation would require more
extensive data than we have collected. Instead, we have used a simpli-
fied theoretical treatment, based on one described by Nir et al. ( 1983,
1986a), to obtain order-of-magnitude information about the aggrega-
tion and disaggregation kinetics of vesicles. Attempting to minimize
the number of adjustable parameters without sacrificing the essential
features of the process, we have used two: C (M -' s-'), the rate con-
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stant of vesicle aggregation, and D (s-1), the rate constant of vesicle
disaggregation. We also have ignored most ofthe dependence ofaggre-
gation rate on the size and morphology of the interacting aggregates.
Following are the rules that govern the model aggregation process.
The notation A (I, J) denotes the molar concentration of aggregate of
(I + J) vesicles, formed from I vesicles with one or more antibodies
available for binding to other vesicles and Jvesicles that do not contain
antibodies.
(a) The antibody-vesicle binding equilibrium is assumed to be es-
tablished before the beginning of aggregation, and these antibodies are
then deemed permanently attached.
(b) Vesicles are divided into two homogeneous categories: those with
and those without bound antibodies. Antibody-containing vesicles are
treated as monovalent with respect to available antibody binding sites.
The multiple haptens on a vesicle are not treated individually. A conse-
quence is that an aggregate can contain no more than one antibody-free
vesicle. In other words, J is either 0 or 1, but I is unconstrained. For
example,
A(1, 0) +A(O, 1) = A(1, 1) , (3)
a+ 0 00
but no further aggregation can occur for
A(1, 1) +A(O, 1) (4)
00 + 0
(c) When two vesicles bind, each containing an available antibody
binding site, only one of the vesicle's antibodies forms the bond be-
tween vesicles (i.e., no double-bonded vesicles):
A(1, O) + A(1, O) = A(2,O) (5)
a + 0 O&
(d) The association rate constant forA (II, J, ) and A (I2, J2) to form
A (II + I2, JI + J2) is proportional to the number of antibody-vesicle
interactions: (6,j + 3J2,0) X C, where bij is equal to 1 if i = j andO
otherwise. In other words, the rate constant is 0, C, or 2C, depending
on whether neither, one, or both the aggregates has a free antibody.
(e) After some experimentation with rules for disaggregation, disag-
gregation was allowed for A (I, 1) and A (2, 0) aggregates but not for
A (I, 0), I > 2. The following depiction can help explain the rationale:
00
->.CJ+0
000 -0 0&+0
In the case of trimers and larger aggregates of the type A (I, 0), cycliza-
tion is possible, and this multivalent interaction should lend increased
stability:
Hence the aggregates A (I, 0), I> 2 were assumed to be formed irrevers-
ibly.
(f ) Where disaggregation was allowed, the rate constant for dissocia-
tion of each bond was D. The computation was based only on the
disaggregation of linear aggregates. Although bivalent antibody-me-
diated bonds between vesicles are symmetric, disaggregation was as-
sumed to take place only at the binding site where aggregation oc-
curred. In other words, antibodies remained permanently attached to
the vesicles to which they were bound before the aggregation.
The computer program solves the nonlinear differential equations of
aggregation kinetics by means of a Taylor expansion. It allows for any
maximum aggregate order, M, but in practice M = 13 was sufficient;
the results forM = 9 or 21 gave similar answers. Cand D are adjusted to
minimize the sum ofthe squares ofdifferences between theoretical and
experimental aggregate distributions.
RESULTS AND DISCUSSION
Differential centrifugation experiments
The four anti-fluorescein MAbs differed significantly in
their ability to precipitate the liposomes (2.9 nM vesi-
cles, hapten 1 mol% of lipid). As shown in Fig. 2 A, all
except MAb 4-4-20 displayed well-defined maxima in
the curves for amount of precipitation vs. antibody con-
centration. Two ofthe MAbs, 2-27-12 and 6-19-1, precip-
itated almost all the vesicles at this maximum (near 300-
400 nM); MAb 2-3-6 precipitated only 40% (near 90
nM), and MAb 4-4-20 at most 10% (throughout a broad
concentration range). Precipitation was specific to the
antibody-hapten interaction: vesicles without hapten
were not precipitated by MAb and nonspecific rabbit
IgG did not precipitate the hapten-bearing vesicles.
The time course ofthe precipitation is shown in Fig. 2
B, where the concentration of each MAb was chosen to
be near that giving maximum precipitation in Fig. 2 A.
The process proceeds in two steps. First, within a few
seconds, the MAb binding to the vesicles comes to equi-
librium, as judged by the completion of fluorescence
quenching (data not shown). Second, on a time scale of
hours, antibody bridges form between the vesicles and
lead to aggregation. Using a similar dansyl hapten/lipo-
some/MAb model system, Luedtke and Karush (1982)
observed precipitation kinetics consistent with the data
presented here for MAbs 6-19-1 and 2-27-12.
The MAb concentration at which maxima, such as
those shown in Fig. 2 A for 6-19-1 and 2-27-12, occur
(MAbo,max) is linearly proportional to vesicle concentra-
tion at constant mole percent hapten. Similarly, decreas-
ing the mole percent hapten (when <1%) leads to a re-
duction in the amount of antibody required for maxi-
mum precipitation and a decrease in the rate of
aggregation (Kantor, 1988).
The existence and nature ofthese maxima follow from
theoretical considerations (von Schulthess, 1976), con-
cluding that aggregation should be maximized when half
the hapten sites are free and half are monovalently
bound by antibody, i.e., when
MAb*H= H='/2HO. (6)
The theoretical and experimental results are consistent
with the classical precipitin behavior of antibodies and
multivalent antigens (Heidelberger and Kendall, 1935;
DeLisi, 1974). At low antibody concentrations, precipi-
tation is limited by the supply of antibodies to cross-link
antigens. At high concentrations, antibodies saturate the
available binding sites on antigens so that a paucity of
free binding sites limits cross-linking. The optimum
amount of precipitation occurs when the product of the
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FIGURE 2 Differential centrifugation oflarge vesicle aggregates. (A) Precipitation curves. MAbs were incubated with vesicles ( 1.0 mol% FG3P, 200
,gM lipid) for 24 h before centrifugation. Vesicles without FG3P were not precipitated by any MAb. Nonspecific rabbit IgG also does not precipitate
the vesicles containing hapten. (B) Kinetics of precipitation. Conditions were chosen from data such as Fig. 2 A to be near maximum precipitation
at long times. Concentrations ofMAb and vesicles and mol percent FG3P were: 2-3-6 (105 nM; 2.9 nM, 1.0%); 2-27-12 (250 nM, 2.9 nM, 1.0%);
4-4-20 (300 nM, 2.9 nM, 1.0%); 6-19-1 (225 nM, 1.43 nM, 0.5%).
concentrations of free hapten sites H and complemen-
tary free binding sites ofantibodies bound monovalently
to antigen MAb -H is maximum. It follows from the von
Schulthess model that MAbo,max oc Ho, i.e., oc the prod-
uct of hapten mole percent and vesicle concentration.
This is indeed observed for MAbs 6-19-1 and
2-27-12.
What factors cause the differences in precipitation be-
havior of the four MAbs? Conformational effects can be
important, as is known for the poor precipitating effi-
ciency of equine IgG(T) (Klinman and Karush, 1967)
and differences in efficiency between (Fab')2 and intact
IgG (Moller, 1979). Isotype-dependent segmental flexi-
bility has been linked to differences in effector function
for murine MAbs (Oi et al., 1984). In our data, the
IgG2's, which are highly flexible, exhibit the extremes of
precipitation efficiency. The two IgG,'s, which are less
flexible, also include both a good and a modest precipita-
tor. Thus, flexibility does not appear to be a dominating
factor here. On the other hand, Fig. 3 shows that the
maximum amount of precipitate in Fig. 2 A correlates
negatively with antibody affinity. Consistent with our
results, the anti-dansyl MAb used by Luedtke and
Karush (1982) had K = 100 (jiM)-1 and was a good
precipitator of dansyl-bearing liposomes.
It may be that affinity modulates the ability ofantibod-
ies to precipitate large aggregates of vesicles by control-
ling the ratio of(intravesicle) bivalently bound to mono-
valently bound antibody. On an isolated vesicle, an equi-
librium should be established quickly between bivalently
bound antibodies and monovalently bound antibodies
plus free hapten. Formal mass-action considerations dic-
tate that the ratio of bivalently to monovalently bound
antibodies will be proportional to the affinity, K, ofanti-
body for hapten, and another factor, a, that accounts for
entropic and steric effects (see, e.g., Crothers and
Metzger, 1972). In the equation below, { } indicates
lateral (two-dimensional) concentrations of reactants:
{MAbH2}/ {MAb.H}= aK{H}. (7)
All else being equal, strongly binding antibodies such as
4-4-20 initially produce vesicles that are less "sticky"
(i.e., have fewer complementary free antibody binding
sites and free hapten) than do more weakly binding anti-
bodies such as 6-19-1. If reorganization of the antibody
binding is required for the extensive aggregation mea-
sured in the centrifugation assay (i.e., intravesicle biva-
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FIGURE 3 Correlation between maximum percent of vesicles precipi-
tated (Fig. 2 A) and antibody affinity (Table 1).
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lent -* monovalent inter-vesicle bivalent), then high
affinity should also limit the aggregation process, be-
cause it correlates with slow dissociation kinetics.
Note that this argument requires the aggregation pro-
cess to be to some extent under kinetic rather than equi-
librium control: at equilibrium, affinity per se is neutral
with respect to intra- versus intervesicular bivalent bind-
ing. The importance of kinetics in multivalent antibody-
membrane interactions has been stressed by Mason and
Williams ( 1980).
To test the relationship between aggregation efficiency
and affinity more strictly, it clearly would be advan-
tageous to have a wider variety of antibodies. A particu-
larly useful strategy would be to control for conforma-
tional factors by testing a series ofantibodies with differ-
ing affinity produced, e.g., by site-directed mutagenesis
in the binding site.
We also studied the ability ofan excess of soluble hap-
ten to interfere with the formation of precipitates for the
case of MAb 6-19-1. Earlier stages of aggregation (1
mol% FG3P, 167 ,uM lipid, 250 nM antibody) can be
reversed by the addition of > 100-fold excess (200 ,uM)
soluble fluorescein. At 5 and 30 min after antibody addi-
tion, the amount of aggregated lipid that can be centri-
fuged is reduced from 50 and 80% to <3%. However, by
2 h the reaction can be only partially reversed (88 down
to 30%). At 24 h, the aggregates cannot be disrupted
with either soluble fluorescein or > 1,000-fold excess (2
mM) fluoresceinamine (a nonfluorescent analogue of
fluorescein that binds the MAb).
Interestingly, however, if the reaction is allowed to
proceed in the presence of inhibitor (either level of solu-
ble fluorescein), it still reaches maximum precipitation
(95%) by 24 h. We speculate that soluble hapten is able
to dissociate small aggregates but not highly intercon-
nected larger aggregates. This may lead to a nucleation-
like phenomenon in which the competition between sol-
uble and vesicle-bound hapten for the antibodies leads to
dynamic fluctuations in aggregate size: most small aggre-
gates dissociate but aggregates that reach a critical size
persist and grow.
Analysis of the early stages
of aggregation
We analyzed the early stages of aggregation by MAb
6-19-1, one of the two most effective precipitators in the
differential-centrifugation experiments. The most im-
portant data were obtained by time-resolved freeze-frac-
ture electron microscopy. This method is restricted to
conditions of high vesicle concentration, so that enough
aggregates can be visualized conveniently to obtain good
statistics. High vesicle concentration implies fast aggre-
gation kinetics, hence it was necessary to reduce the num-
ber of haptens per vesicle considerably to slow the pro-
cess enough that aliquots could be collected and frozen
over a period of minutes before the aggregation had pro-
ceeded too far. We found turbidimetry a convenient
source of semi-quantitative information about the early
events in aggregation, and useful for further establishing
conditions suitable for electron microscopy as well.
Turbidity experiments
Given that the diameters ofthe vesicles are near the wave-
length of visible light, interference effects make it hard to
interpret turbidity changes quantitatively in terms ofde-
gree ofaggregation. The antibody by itselfin solution did
not contribute significantly to the turbidity. Neverthe-
less, the initial binding of the antibodies to the hapten-
bearing vesicles resulted in an increase in the turbidity
(see curve D2 in Fig. 4 A for the initial increase in the
turbidity caused by Fab binding to the vesicles). A simi-
lar phenomenon has been reported in other cases (Nel-
sestuen and Lim, 1977). However, in our case a signifi-
cant percentage of the turbidity increase within 30 s also
can be attributed to vesicle aggregation.
Three control experiments showed that the aggrega-
tion was induced by specific intervesicular cross-linking
ofthe hapten-containing vesicles by bivalent antibodies.
First, vesicles without the hapten did not aggregate in the
presence of MAb 6-19-1 (curve Dl, Fig. 4 A); the
changes in the turbidity over 30 min were <2.5% of the
level of liposomes alone, indicating that the nonspecific
interactions among the vesicles are negligible on the time
scale of minutes even in the presence of antibody. Sec-
ond, using just the monovalent Fab fragments of MAb
4-4-20 did not result in the aggregation of hapten-con-
taining vesicles (curve D2, Fig. 4 A). Third, the aggrega-
tion could be inhibited by a 20-fold excess of soluble
fluorescein over FG3P (curve D3, Fig. 4 A), which effec-
tively competes with the membrane-bound hapten on
the time scale of these measurements. All of the above
controls are consistent with the controls for the differen-
tial-centrifugation experiments.
MAb 6-19-1 (curve B, Fig. 4 A) was more effective
than MAb 4-4-20 (curve C, Fig. 4 A) at forming small
vesicle aggregates. This is similar to the results of the
differential-centrifugation experiments. Doubling the
surface concentration of FG3P from 0.05% (curve B) to
0.10% (curve A) enhanced the rate of turbidity increase.
The decrease in the turbidity at the later stage ofaggrega-
tion in curve A was due to the formation and fast sedi-
mentation oflarge aggregates out ofthe light beam in the
cuvette. For the conditions monitored, increasing the
antibody concentration (Fig. 4 B) had a greater effect on
the rate of the aggregation than did increasing lateral
hapten concentration.
EM: specificity of aggregation and test
for fusion
The control experiments done for the turbidimetric mea-
surement and differential centrifugation were also con-
firmed by freeze-fracture EM; aggregation ofvesicles was
not induced either by adding Fab fragments to the hap-
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FIGURE 4 (A) Aggregation ofliposomes monitored by turbidimetry. Curves A and B show the percent turbidity change upon adding MAb 6-19-1
to vesicles containing 0.10 and 0.05 mol% FG3P, respectively. Curve C shows the aggregation induced by MAb 4-4-20 under the same conditions.
Curve Dl shows the turbidity change upon adding MAb 6-19-1 to the vesicles containing no haptens, curve D2 upon adding 4-4-20 Fab to the
vesicles with hapten, and curve D3 under the same condition as in B except the presence of excess sodium fluorescein. The curves Dl and D3
coincided with each other at this scale. For all cases, the lipid concentration was 7.5 mM, and there were 4.5 antibodies per vesicle ( 1.7 ,uM binding
site concentration). (B) Effect of concentration ofMAb 6-19-1 on the aggregation rate. Vesicles were incubated with a fourfold range of antibody
concentration ( 1.1-4.5 antibodies added per vesicle). All the vesicles contained 0.05 mol% FG3P, and the lipid concentration was 3.75 mM.
ten-containing vesicles, by adding antibodies in the pres-
ence of excess soluble fluorescein, or by adding antibod-
ies to the vesicles containing no hapten. The possibility
of fusion among the aggregated liposomes was elimi-
nated by comparing the size of the vesicles before and
after the addition of antibody within the timescale of
experiments. The mean and standard deviation of vesi-
cle diameters were 58.1 nm and 11.4 nm before adding
antibodies, and 59.6 nm and 11.9 nm afterward; these
are not significantly different. Nor were structures ob-
served that resembled fusion intermediates or products
(Bearer et al., 1983).
EM: morphology of aggregates
The addition ofMAb 6-19-1 to the suspension ofmono-
meric vesicles induced the formation of dimers, trimers,
and so on. The typical morphology ofthese small aggre-
gates is shown in Figs. 5 and 6. Dimers appeared in
freeze-fracture replicas either as two adjacent convex (or
concave) hemispheres or one convex and the other con-
cave hemisphere. Both cases are shown in Fig. 5. In the
latter case, the apparent distance between the vesicles
probably approximates the distance of closest approach.
This is near the dimensions of an IgG molecule ( - 10-
15 nm). There sometimes appeared a feature in the con-
tact area between vesicles that could have been an IgG
molecule bridging the vesicles; this is seen in Fig. 5.
Trimers tended to be triangular rather than linear, as is
shown in Fig. 6, but the connections among three vesi-
cles in a trimer were not normally symmetrical. Large
aggregates showed a striking difference from the mor-
phology ofnegatively charged vesicles whose aggregation
was induced by cations (Day et al., 1980; Hui et al.,
1988). The contact area between the aggregated vesicles
was smaller than the contact area in the cation induced
aggregation, even in the large aggregates.
EM: evolution of aggregation
The time course of aggregation was followed by EM
under conditions where vesicles were concentrated ( 15
mM lipid, 0.4 ,AM vesicles) but in which the rate of ag-
gregation was slowed by low antibody and hapten con-
centrations ( 1.1 antibodies per vesicle, 0.05 mol% hap-
ten). These conditions are identical to those for the slow-
est aggregation shown in Fig. 4 B except for the fourfold
higher concentration of vesicles used for EM.
Fig. 7 (A through D) shows typical areas ofthe freeze-
fracture replicas at 0, 2, 6, and 15 min after the antibod-
ies were added. The apparent distribution of the aggre-
gate sizes at each time point is shown in Fig. 8 and Table
2. Because the visualized aggregates may represent only
sections through larger aggregates, the stereological cor-
rection described in Materials and Methods was applied
to the apparent distribution; the results are shown in Ta-
ble 2.
Without knowing more about the processes that direct
the fractures, it is difficult to say which data set repre-
sents the aggregate distribution more accurately. Fortu-
nately, both show the same qualitative picture of the ag-
gregation process. There is a rapid drop in the percentage
ofmonomeric vesicles during the first 2 min, followed by
a much slower decline. Over the period 2-15 min, the
percentage of vesicles in dimers tends to fall and that in
trimers to rise. The percentage of vesicles in tetramers
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FIGURE 5 Typical freeze-fracture electron micrographs showing the morphology of dimers. The bar represents 0.02 ,uM.
(or larger aggregates) rises monotonically. The behavior
of dimer and trimer percentages, particularly in the
corrected distribution, is similar to the rise and fall of
intermediates in a sequential chemical reaction.
Perhaps the most striking feature of the data is the
failure of the aggregation to go to completion, as judged
by monomer content, after a rapid beginning. This
largely reflects the stochastic distribution of antibodies
among vesicles that leaves about one third ofthe vesicles
without antibodies and therefore unable to participate
fully in the aggregation. Likewise, many vesicles do not
precipitate at low MAb/vesicle ratios in the differential
centrifugation experiments even after 24 h.
Theoretical modeling of aggregation
The aggregation model described in Materials and Meth-
ods was fit to the EM results in Fig. 8 by adjusting the
forward and reverse rate constants for vesicle aggrega-
tion (C and D). Four different fits were performed (Ta-
ble 2): to the apparent and stereologically corrected data
and assuming that either none or 30% of the antibodies
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FIGURE 6 Typical freeze-fracture electron micrographs showing the morphology of trimers and larger aggregates. These micrographs were taken
during the experiments reported in Figs. 7 and 8. The bars represent 0.02 gm except where noted otherwise.
bound bivalently intravesicularly and thereby were re-
moved from the aggregation process.
The sensitivity of the fit to values of the adjustable
parameters C and D is similar for all four calculations
shown in Table 2. When D is varied by 10% about its
optimum (with C fixed), the root-mean-square (RMS)
error of the fit rises by 2% (i.e., is multiplied by 1.02).
Similarly, varying Cand fixingD yields a 10% rise. Thus,
the goodness of fit is less sensitive to small variations in
D than in C. When C and D are simultaneously doubled
(keeping their ratio, a measure of affinity, fixed), the
error increases by 50%; when they are halved, the error
increases threefold. The decision to allow dimers oftype
A(2, 0) to disaggregate was motivated by an overesti-
mate of dimer concentrations when such disaggregation
was not allowed.
The amount ofintravesicle bivalency affected the char-
acter of the fit in a minor way but the values ofC and D
almost not at all. The fit to the apparent data was signifi-
cantly better than to the corrected data; the values of C
differed by about threefold and those ofD were nearly
the same. Considering these factors as well as the sensitiv-
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FIGURE 7 Typical freeze-fracture electron micrographs showing the evolution ofvesicle aggregation. The aggregation was monitored at 0 min (A),
2 min (B), 6 min (C), and 15 min (D) after adding antibodies. Lipid concentration was 15 mM, antibody binding site concentration 850 nM, FG3P
concentration 0.05 mol% of lipids. The bars represent 0.2 um.
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FIGURE 7 (continued)
ity of the RMS error discussed above, we estimate that
the most realistic value of C lies in the range 2 x 104 to
1 X 105 M-1 s-51 whereas that for D is roughly 4 X l0
to I X lO-2 s-1 .
These rate constants for aggregation and disaggrega-
tion are one to two orders of magnitude lower than the
corresponding values for the interaction of Fab frag-
ments with the same hapten-bearing vesicles ( 1.6 X 106
M` s-' and 0.5 s-', determined by fluorescence-
quenching methods similar to those of Petrossian and
Owicki, 1984). Given that C is expressed in terms of
concentration ofvesicles, each ofwhich contains 12 hap-
tens, the effective reduction in the rate constant for for-
mation of antibody-hapten bonds is really two to three
orders of magnitude. The rate constants for Fab interact-
ing with FG3P on a vesicle are themselves three to four
times lower than the rate constants for Fab or antibody
interacting with sodium fluorescein (5 X 106 M` s-'
and 2 s-1).
Thus, there is a strong trend toward lower rate con-
stants as the antibody and hapten are attached to bulky
carriers. The larger diffusive size of the vesicle-bound
reactants, coupled with a restricted reactive area and the
potential barrier for a close approach ofvesicles, presum-
ably contribute to this trend (see, e.g., DeLisi, 1980).
Conformational constraints that make it difficult for an
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FIGURE 8 Apparent aggregate-size distribution obtained from freeze-
fracture EM. Data are presented as percent of vesicles in each aggregate
size and were pooled from two independent experiments to construct
the distribution ofaggregate size at 0, 2, 6, and 15 min after the addition
ofantibody. The conditions were the same as in Fig. 7. A total of 1,000
vesicles each was counted for the 0- and 2-min time points, and 400
each for the 6- and 1 5-min time points.
antibody simultaneously to bind haptens on apposed ves-
icles also may be present. The decrease in association/
aggregation rate is orders of magnitude too large to be
explained solely by antibody-hapten binding operating
with translational diffusion coefficients appropriate for
vesicles. The slowing of kinetics due to the inhomo-
geneous three-dimensional distribution of membrane-
bound reactants analyzed by Berg and Purcell ( 1977) is
not important here, both because the reactions in our
system are not appreciably under diffusion control and
because the distribution is not sufficiently inhomo-
geneous. Additional data, perhaps obtained with differ-
ent MAbs, would be required to narrow the possibilities
for the mechanism of the slowing.
Our results also can be compared with aggregation
processes that are not mediated by ligand-receptor-like
interactions, i.e., when similar size particles are uni-
formly reactive over their entire surface. The value ofC
found in our studies is four orders below that in diffu-
sion-controlled reactions (Smoluchowski, 1917) or two
orders of magnitude below that in (650 mM) Na+-in-
duced or (2 mM) Ca2+-induced aggregation ofphospha-
tidylserine vesicles (Day et al., 1980; Bentz and Nir,
1981; Nir et al., 1983; Hui et al., 1988).
The ratio C/D for our system, which can be inter-
preted as an affinity for dimer formation, is probably in
the range 2 x 106 to 2 x I07 M'-l. To be compared with
the affinity of Fab for hapten on the vesicle (3 x 106
M-1), this should be divided by the number of haptens
per vesicle ( 12), giving a range of 2 x I05 to 2 x 106
M'- . It is reasonable that steric effects involved in cross-
linking vesicles should lower the affinity, but one must
be wary of overinterpreting the results of this approxi-
TABLE 2 Experimental and calculated distributions of aggregate sizes
Apparent distribution* Corrected distribution**
Vesicles Calculatedll Calculatedll
per aggregate Experimentalg Calculated (30% bivalent) Experimental Calculated (30% bivalent)
At t = 2 min
1 58±2 55 56 41 ±2 34 36
2 21 ± 1 25 25 26 ± 2 23 24
3 11±1 13 12 8±3 20 19
.4 10± 1 7 7 26±2 23 21
At t = 6 min
1 44 ± 2 41 44 27 ± 3 28 32
2 22+2 19 21 15±3 17 20
3 20±2 17 16 32±4 17 17
>4 14±2 23 19 26±4 38 31
At t = 15 min
1 39±3 37 40 21 ± 3 28 32
2 15 ± 3 15 17 6 ± 4 16 19
3 17±3 14 14 25±5 15 16
.4 29±3 34 29 47 ±7 41 33
Best fit C(M-' s-') 3 x 104 3 x 104 8 x 104 9 X 104
Best fit D (s-') 0.006 0.006 0.008 0.008
RMS error in fit' 4.2 2.9 9.3 10.2
* Percent of vesicles in each aggregate size.
$ Based on stereological correction.
§ Range is standard deviation based on Poisson counting statistics for the vesicles.
Assuming 30% of the MAb binds bivalently intravesicularly and is removed from the aggregation process.
'Computed as [E (calc1-exptli)2/(N - 2)]'/2, where i runs over the N = 12 data points (four aggregate sizes times three time points).
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TABLE 3 Calculated effect of MAb/vesicle ratio
on aggregation process*
MAb per vesiclet
Vesicles per aggregate 1.1 2.3 4.5
At t = 1 min
1 82 74 65
2 15 19 23
3 2 5 9
.4 1 2 3
At t = 2 min
1 75 63 54
2 19 22 22
3 5 10 14
.4 1 5 10
At t = 6 min
1 67 48 32
2 19 16 10
3 8 13 14
.4 6 23 44
* The kinetic parameters are those obtained for the corrected distribu-
tion: C = 9 x 104 M-l s-l and D = 0.008 s-', assuming 30% intravesicu-
lar binding of the MAb. Vesicle concentration is 0.1 sM, and the per-
cents of vesicles without available antibodies for intervesicular bivalent
binding are 50, 24, and 4, for 1.1, 2.3, and 4.5 MAb/vesicle, respec-
tively.
t Distribution (percent of vesicles in each aggregate size).
mate model. Nevertheless, it is noteworthy that attach-
ing the reactants to vesicles has much smaller effects on
affinity than on kinetics.
We have used the model to predict the effects ofMAb/
vesicle ratio on the aggregation process. Table 3 shows
the results for 1.1, 2.3, and 4.5 MAb per vesicle under
conditions identical to those for the turbidimetric exper-
iments reported in Fig. 4 B. Although the actual distri-
bution of aggregates cannot be deduced from turbidity
measurements and it is hard to calculate changes in tur-
bidity from the known distribution ofaggregates, we can
make qualitative comparisons between the theoretical
and turbidimetric results. We may take the percent of
vesicles in monomers or the average aggregate size as a
measure for the development ofthe aggregation process.
A comparison of Table 2 with Table 3 (first column, 1.1
MAb per vesicle) indicates that for the same time points,
e.g., 2 and 6 min, there is less aggregation in the latter
case because of fourfold reduction in vesicle concentra-
tion. According to Table 3, the aggregation process is
more developed for the case with 2.3 MAb per vesicle at
1 and 2 min than for the case with 1.1 MAb per vesicle at
2 and 6 min, respectively. This is in accord with the
turbidity results in Fig. 4 B. A similar agreement holds
for additional cases, but overall the turbidity data de-
pend more steeply on MAb/vesicle ratio than do the
theoretical results in Table 3. This partly may be due to
nonlinearities in the relationship between turbidity and
extent of aggregation. It probably also results from the
way the theory incorporates the MAb/vesicle ratio: add-
ing more MAbs decreases the number ofvesicles without
antibodies but it does not formally increase Cor decrease
D as the number of antibodies bound per vesicle in-
creases. Hence, the theory is most applicable at low
MAb/vesicle ratios. In addition, we can anticipate that
more intravesicular binding should occur at lower con-
centrations ofvesicles used for Fig. 4 B and that the prob-
ability of intravesicular binding should decrease in the
presence of larger ratios of MAb/vesicle. We have not
explicitly accounted for these effects since the simulation
of the EM results focussed on the 1.1 ratio and more
concentrated vesicle suspensions.
CONCLUSION
The antibody-hapten mediated aggregation of vesicles is
a convenient model for more complex biological sys-
tems, such as virus-cell or cell-cell interactions, since we
had the advantage ofvarying both receptor (hapten) and
ligand (antibody) concentrations. We have shown that
at low (micromolar) lipid concentrations the system dis-
plays relatively classical precipitin behavior with some
MAbs. Others produce scant precipitation. We suggest
that antibody affinity is an important determinant of
this behavior: sufficiently high-affinity antibodies bind
bivalently to a single vesicle and are kinetically unable to
participate in aggregation. At high (millimolar) lipid
concentrations, we have followed the aggregation by EM
and turbidimetry and by a theoretical model based on
mass-action kinetics. We have reported the morpholo-
gies of small aggregates and have found that the rates of
the process are slowed by orders ofmagnitude compared
either with the binding of antibodies to hapten-contain-
ing vesicles or with the cation-induced aggregation of
negatively charged vesicles. The apparent affinity for ag-
gregating vesicles is reduced less.
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